Javascript must be enabled to continue!
Aza-BODIPY-based Fluorescent and Colorimetric Sensors and Probes
View through CrossRef
Abstract:
Aza-boron-dipyrromethenes (Aza-BODIPYs) represent an important class of chromo-phores absorbing and emitting in the near-infrared (NIR) region. They have unique optical and elec-tronic features and higher physiological and photo stability than other NIR dyes. Especially after the development of facile synthetic routes, Aza-BODIPYs have become indispensable fluors that can find various applications ranging from chemosensors, bioimaging, phototherapy, solar energy materials, photocatalysis, photon upconversion, lasers, and optoelectronics. Herein, we review Aza-BODIPY based fluorescent and colorimetric chemosensors. We show the potential and untapped toolbox of Aza-BODIPY based fluorescent and colorimetric chemosensors. Hence, we divide the fluorescent and colorimetric chemosensors and probes into five sections according to the target ana-lytes. The first section begins with the chemosensors developed for pH. Next, we discuss Aza-BODIPY based ion sensors, including metal ions and anions. Finally, we present the chemosensors and probes concerning reactive oxygen (ROS) and nitrogen species (RNS) along with biologically relevant species in the last two sections. We believe that Aza-BODIPYs are still in their infancy, and they have a promising future for translation from the bench to real biomedical and materials science applications. After two decades of intensive research, it seems that there are many more to come in this already fertile field. Overall, we hope that future work will further expand the applica-tions of Aza-BODIPY in many areas.
Bentham Science Publishers Ltd.
Title: Aza-BODIPY-based Fluorescent and Colorimetric Sensors and Probes
Description:
Abstract:
Aza-boron-dipyrromethenes (Aza-BODIPYs) represent an important class of chromo-phores absorbing and emitting in the near-infrared (NIR) region.
They have unique optical and elec-tronic features and higher physiological and photo stability than other NIR dyes.
Especially after the development of facile synthetic routes, Aza-BODIPYs have become indispensable fluors that can find various applications ranging from chemosensors, bioimaging, phototherapy, solar energy materials, photocatalysis, photon upconversion, lasers, and optoelectronics.
Herein, we review Aza-BODIPY based fluorescent and colorimetric chemosensors.
We show the potential and untapped toolbox of Aza-BODIPY based fluorescent and colorimetric chemosensors.
Hence, we divide the fluorescent and colorimetric chemosensors and probes into five sections according to the target ana-lytes.
The first section begins with the chemosensors developed for pH.
Next, we discuss Aza-BODIPY based ion sensors, including metal ions and anions.
Finally, we present the chemosensors and probes concerning reactive oxygen (ROS) and nitrogen species (RNS) along with biologically relevant species in the last two sections.
We believe that Aza-BODIPYs are still in their infancy, and they have a promising future for translation from the bench to real biomedical and materials science applications.
After two decades of intensive research, it seems that there are many more to come in this already fertile field.
Overall, we hope that future work will further expand the applica-tions of Aza-BODIPY in many areas.
Related Results
Azacitidine-panobinostat activates NF-kb signaling in the bone marrow microenvironment to chemosensitize KMT2A rearranged pediatric AML
Azacitidine-panobinostat activates NF-kb signaling in the bone marrow microenvironment to chemosensitize KMT2A rearranged pediatric AML
Abstract
KMT2A rearrangements (KMT2Ar), a hallmark of pediatric acute leukemia, are present in 20% of pediatric acute my...
Evaluation Of Acadesine, a Drug Stimulating Cell Autophagy, In Azacitidine(AZA)-Resistant Myelodysplastic Syndromes (MDS)
Evaluation Of Acadesine, a Drug Stimulating Cell Autophagy, In Azacitidine(AZA)-Resistant Myelodysplastic Syndromes (MDS)
Abstract
Background
AZA is currently the first line treatment for intermediate-2 and high-risk IPSS myelodysplastic syndromes (M...
An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
In this article, we present a Japanese female case of cutaneous small vessel vasculitis (CSVV) after administration of oral azathioprine (AZA).
A 56-year-old Japanese woman with l...
Modulation of CD81 By Epigenetic Drug Combination Sensitizes Acute Lymphoblastic Leukemia Via Decreased BTK Signaling
Modulation of CD81 By Epigenetic Drug Combination Sensitizes Acute Lymphoblastic Leukemia Via Decreased BTK Signaling
Background
We previously discovered that the epigenetic drug combination - azacitidine (aza, DNMTi) and panobinostat (pano, HDACi) can sensitize ALL cells to chemoth...
pVAX14 DNA, An Immunoadjuvant, Extends Life-Span As Add-On Treatment To Azacitidine (AZA) In A Mouse Model Of High Risk Myelodysplastic Syndrome (HR-MDS)
pVAX14 DNA, An Immunoadjuvant, Extends Life-Span As Add-On Treatment To Azacitidine (AZA) In A Mouse Model Of High Risk Myelodysplastic Syndrome (HR-MDS)
Abstract
Background
We have established animal models of MDS and acute myelogenous leukemia (AML) using NRASD12 and overexpressi...
PTU-075 Long Term outcome of Azathioprine Therapy in 353 Consecutive IBD Patients
PTU-075 Long Term outcome of Azathioprine Therapy in 353 Consecutive IBD Patients
Introduction
Thiopurines are the mainstay of therapy in Inflammatory Bowel Disease (IBD). Azathioprine (AZA) and Mercaptopurine are very effective at maintaining ...
Heterotricyclodecane. XXIV. 2‐Aza‐7‐oxa‐twistane (bzw. 2‐Oxa‐7‐aza‐twistane) und 2‐Aza‐7‐oxa‐isotwistane
Heterotricyclodecane. XXIV. 2‐Aza‐7‐oxa‐twistane (bzw. 2‐Oxa‐7‐aza‐twistane) und 2‐Aza‐7‐oxa‐isotwistane
2‐Aza‐7‐oxa‐twistanes (or 2‐oxa‐7‐aza‐twistanes, respectively)Die nicht mit den IUPAC‐Regeln übereinstimmende Numerierung (b): 2‐Aza‐7‐oxa‐twistane, Substituent an C(10) (vgl. Korr...
5-Azacytidine Versus Intensive Chemotherapy or BSC in Elderly (>60 years) Acute Myeloid Leukemia Patients. A Retrospective Analysis
5-Azacytidine Versus Intensive Chemotherapy or BSC in Elderly (>60 years) Acute Myeloid Leukemia Patients. A Retrospective Analysis
Abstract
Abstract 2612
BACKGROUND:
5-Azacytidine (AZA) has proven to prolong overall survival (OS) in higher-risk...

